FDA.reportPublic FDA data

Application 020164

Type
NDA
Sponsor
SANOFI AVENTIS US

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS30MG/0.3ML (100MG/ML)YesNo
002LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS40MG/0.4ML (100MG/ML)YesNo
003LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS60MG/0.6ML (100MG/ML)YesNo
004LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS80MG/0.8ML (100MG/ML)YesNo
005LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS100MG/ML (100MG/ML)YesYes
006LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
007LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS120MG/0.8ML (150MG/ML)YesNo
008LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUMINJECTABLE;SUBCUTANEOUS150MG/ML (150MG/ML)YesNo
009LOVENOXENOXAPARIN SODIUMINJECTABLE;INTRAVENOUS, SUBCUTANEOUS300MG/3ML (100MG/ML)YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020164-001LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM30MG/0.3ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1993-03-29
N020164-002LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM40MG/0.4ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-01-30
N020164-003LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM60MG/0.6ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27
N020164-004LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM80MG/0.8ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27
N020164-005LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM100MG/ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD, RS1998-03-27
N020164-006LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / SUBCUTANEOUSRLD2000-06-02
N020164-007LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM120MG/0.8ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-02
N020164-008LOVENOX (PRESERVATIVE FREE)ENOXAPARIN SODIUM150MG/ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-02
N020164-009LOVENOXENOXAPARIN SODIUM300MG/3ML (100MG/ML)INJECTABLE / INTRAVENOUS, SUBCUTANEOUSABRLD2003-01-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 8 matching rows.

Application-product, TE code table
Application-productTE code
N020164-001AP
N020164-002AP
N020164-003AP
N020164-004AP
N020164-005AP
N020164-007AP
N020164-008AP
N020164-009AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 10 · 378 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N020164-001LOVENOX (PRESERVATIVE FREE)30MG/0.3ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1993-03-29caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-002LOVENOX (PRESERVATIVE FREE)40MG/0.4ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-01-30caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-003LOVENOX (PRESERVATIVE FREE)60MG/0.6ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-004LOVENOX (PRESERVATIVE FREE)80MG/0.8ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-005LOVENOX (PRESERVATIVE FREE)100MG/ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD, RS1998-03-27caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-006LOVENOX (PRESERVATIVE FREE)90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / SUBCUTANEOUSRLD2000-06-02caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-007LOVENOX (PRESERVATIVE FREE)120MG/0.8ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-02caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-008LOVENOX (PRESERVATIVE FREE)150MG/ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-02caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-009LOVENOX300MG/3ML (100MG/ML)INJECTABLE / INTRAVENOUS, SUBCUTANEOUSABRLD2003-01-23caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020164-001LOVENOX (PRESERVATIVE FREE)30MG/0.3ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1993-03-29011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-002LOVENOX (PRESERVATIVE FREE)40MG/0.4ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-01-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-003LOVENOX (PRESERVATIVE FREE)60MG/0.6ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-004LOVENOX (PRESERVATIVE FREE)80MG/0.8ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-005LOVENOX (PRESERVATIVE FREE)100MG/ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD, RS1998-03-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-006LOVENOX (PRESERVATIVE FREE)90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / SUBCUTANEOUSRLD2000-06-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-007LOVENOX (PRESERVATIVE FREE)120MG/0.8ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-008LOVENOX (PRESERVATIVE FREE)150MG/ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-009LOVENOX300MG/3ML (100MG/ML)INJECTABLE / INTRAVENOUS, SUBCUTANEOUSABRLD2003-01-23011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-001LOVENOX (PRESERVATIVE FREE)30MG/0.3ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1993-03-2931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-002LOVENOX (PRESERVATIVE FREE)40MG/0.4ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-01-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-003LOVENOX (PRESERVATIVE FREE)60MG/0.6ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-004LOVENOX (PRESERVATIVE FREE)80MG/0.8ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-005LOVENOX (PRESERVATIVE FREE)100MG/ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD, RS1998-03-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-006LOVENOX (PRESERVATIVE FREE)90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / SUBCUTANEOUSRLD2000-06-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-007LOVENOX (PRESERVATIVE FREE)120MG/0.8ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-008LOVENOX (PRESERVATIVE FREE)150MG/ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-009LOVENOX300MG/3ML (100MG/ML)INJECTABLE / INTRAVENOUS, SUBCUTANEOUSABRLD2003-01-2331067a03dcf5…
2025-08-23 18:47 UTC2025-08N020164-001LOVENOX (PRESERVATIVE FREE)30MG/0.3ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1993-03-296a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-002LOVENOX (PRESERVATIVE FREE)40MG/0.4ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-01-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-003LOVENOX (PRESERVATIVE FREE)60MG/0.6ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-004LOVENOX (PRESERVATIVE FREE)80MG/0.8ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-005LOVENOX (PRESERVATIVE FREE)100MG/ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD, RS1998-03-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-006LOVENOX (PRESERVATIVE FREE)90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / SUBCUTANEOUSRLD2000-06-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-007LOVENOX (PRESERVATIVE FREE)120MG/0.8ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-008LOVENOX (PRESERVATIVE FREE)150MG/ML (150MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD2000-06-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-009LOVENOX300MG/3ML (100MG/ML)INJECTABLE / INTRAVENOUS, SUBCUTANEOUSABRLD2003-01-236a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-001LOVENOX (PRESERVATIVE FREE)30MG/0.3ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1993-03-29fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-002LOVENOX (PRESERVATIVE FREE)40MG/0.4ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-01-30fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-003LOVENOX (PRESERVATIVE FREE)60MG/0.6ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-004LOVENOX (PRESERVATIVE FREE)80MG/0.8ML (100MG/ML)INJECTABLE / SUBCUTANEOUSAPRLD1998-03-27fd3edfee7708…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 9 · 336 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07N020164-001AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-002AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-003AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-004AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-005AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-007AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-008AP1caaa826d4ba7…
2026-08-18 06:07:402026-07N020164-009AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020164-001AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-002AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-003AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-004AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-005AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-007AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-008AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020164-009AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-001AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-002AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-003AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-004AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-005AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-007AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-008AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020164-009AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020164-001AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-002AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-003AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-004AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-005AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-007AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-008AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020164-009AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-001AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-002AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-003AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-004AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-005AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-007AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-008AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020164-009AB1fd3edfee7708…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LovenoxENOXAPARIN SODIUMSanofi-Aventis U.S. LLC5017a927-2a24-4f27-89f9-27c805bf7d592026-05-28Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020164
application number: NDA020164
ndc (product): 0075-2915
ndc (product): 0075-0626
ndc (product): 0075-0624
ndc (product): 0075-0622
ndc (product): 0075-0621
ndc (product): 0075-0623
ndc (product): 0075-2912
ndc (product): 0075-0620
LovenoxENOXAPARIN SODIUMCardinal Health 107, LLC3d263380-4f44-4fd8-aa2a-e69702ab258f2026-04-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020164
application number: NDA020164
LovenoxENOXAPARIN SODIUMSanofi-Aventis U.S. LLCde6fb917-a94a-41ea-9d7d-937d4080ffcd2026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020164
application number: NDA020164
ndc (product): 0075-8020
ndc (product): 0075-8025
ndc (product): 0075-8016
ndc (product): 0075-8013
ndc (product): 0075-8022
ndc (product): 0075-8014
ndc (product): 0075-8018
Enoxaparin sodiumENOXAPARIN SODIUMSanofi-Aventis U.S. LLC20635579-c92d-4f6c-a332-1096d51002f22026-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020164
application number: NDA020164
Enoxaparin SodiumENOXAPARIN SODIUMFresenius Kabi USA, LLC21b095d1-5ade-43e9-9114-30fbfb2331c92026-02-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020164
application number: NDA020164
Enoxaparin SodiumENOXAPARIN SODIUMFresenius Kabi USA, LLC066f27ec-352c-4051-ba29-248e292690db2026-02-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 020164
application number: NDA020164

NDC Listings For This Application#

NDC listings for this application page 1 of 4 · 268 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0075-0620Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0620Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0620Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0620Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-0620Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0620Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0621Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0621Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0621Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0621Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-0621Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0621Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0622Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0622Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0622Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0622Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-0622Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0622Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0623Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0623Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0623Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0623Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-0623Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0623Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0624Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0624Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0624Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0624Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-0624Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0624Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0626Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0626Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0626Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0626Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-0626Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-0626Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2912Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2912Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2912Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2912Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-2912Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2912Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2915Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2915Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2915Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2915Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-2915Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-2915Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8013Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8013Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-8013Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8013Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8013Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8014Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8014Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-8014Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8014Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8014Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8016Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8016Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-8016Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8016Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8016Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8018Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8018Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-8018Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8018Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8018Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8020Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8020Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-8020Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8020Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8020Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8022Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8022Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent
0075-8022Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8022Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8022Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8025Lovenoxenoxaparin sodiumSanofi-Aventis U.S. LLCNDACurrent
0075-8025Lovenoxenoxaparin sodiumsanofi-aventis U.S. LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74941SUPPL 2023-07-31
74940SUPPL 2023-07-31
72775SUPPL2022-12-05
72770SUPPL2022-12-02
69729SUPPL2021-12-21
69699SUPPL2021-12-20
56839SUPPL2018-12-20
56710SUPPL2018-12-12
50280SUPPL2017-11-03
50238SUPPL2017-10-31
44049ORIG2013-11-07
34335SUPPL2013-10-31
21249SUPPL2013-10-25
34334SUPPL2013-06-11
2128SUPPL2013-06-07
2127SUPPL2011-04-22
12290SUPPL2011-04-21
34333SUPPL2011-04-19
2126SUPPL2011-04-15
21248SUPPL2009-12-31
12289SUPPL2009-12-30
21247SUPPL2009-07-31
34332SUPPL2009-07-30
20515SUPPL2009-03-24
41182SUPPL2008-08-11
20506SUPPL2008-08-11
20505SUPPL2008-08-11
20504SUPPL2008-08-11
20503SUPPL2008-08-11
41188SUPPL2008-08-08
41187SUPPL2008-08-08
41186SUPPL2008-08-08
41184SUPPL2008-08-08
20509SUPPL2008-08-08
20508SUPPL2008-08-08
20507SUPPL2008-08-08
41197SUPPL2008-08-04
41196SUPPL2008-08-04
41195SUPPL2008-08-04
41194SUPPL2008-08-04
41193SUPPL2008-08-04
41192SUPPL2008-08-04
41191SUPPL2008-08-04
41190SUPPL2008-08-04
41189SUPPL2008-08-04
20511SUPPL2008-08-04
41198SUPPL2008-08-01
20514SUPPL2008-08-01
20512SUPPL2008-08-01
20510SUPPL2008-08-01
12288SUPPL2008-07-22
21246SUPPL2008-07-18
41200SUPPL2007-07-09
41199SUPPL2007-07-09
21245SUPPL2007-05-29
12287SUPPL2007-05-29
34331SUPPL2007-01-16
2125SUPPL2007-01-16
20513SUPPL2006-10-26
2124SUPPL2005-03-10
21241SUPPL2004-10-26
21242SUPPL2004-07-28
12286SUPPL2004-07-28
20502ORIG2004-07-15
2114SUPPL2004-06-08
2123SUPPL2004-05-26
21244SUPPL2004-04-29
21243SUPPL2004-04-20
34328ORIG2004-04-05
21236ORIG2004-02-25
2120SUPPL2003-12-23
2121SUPPL2003-07-08
2122SUPPL2003-07-06
41183SUPPL2003-04-29
21239SUPPL2003-01-23
21240SUPPL2002-01-09
21238SUPPL2002-01-09
2119SUPPL2002-01-09
34330SUPPL2000-11-17
21237SUPPL2000-11-17
12285SUPPL2000-11-17
2118SUPPL2000-11-17
2117SUPPL2000-09-27
2116SUPPL2000-08-04
41185SUPPL2000-07-03
34329SUPPL1998-12-31
2115SUPPL1998-12-31